Tonix Pharm Hldg (TNXP) Posts Q1 Loss of 59c/Share

Tonix Pharm Hldg (NASDAQ: TNXP) reported Q1 EPS of ($0.59), $0.24 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Tonix Pharm Hldg (TNXP) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• CRH plc (CRH) PT Lowered to $135 at UBS, Buy Rating Maintained
• Ennis (EBF) Misses Q2 EPS by 2c